Literature DB >> 2850050

Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria.

G Boivin1, P Mesguich, J W Pike, R Bouillon, P J Meunier, M R Haussler, P M Dubois, G Morel.   

Abstract

Immunoreactivity to 1,25-dihydroxyvitamin D3 receptors and endogenous 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) were studied in osteoblasts and osteocytes from calvaria of neonatal mice and rats by immunocytochemistry with the use of ultrathin sections obtained by cryo-ultramicrotomy. Tissue samples were fixed in glutaraldehyde, postfixed in osmium tetroxide and frozen under liquid nitrogen. 1,25(OH)2D3 and 1,25(OH)2D3 receptor-like immunoreactivities were observed in osteoblasts and osteocytes. In both types of cell, 1,25(OH)2D3 and its receptors were similarly located in the cytoplasmic matrix but not in organelles, and mainly in the nucleus (primarily in the chromatin and sometimes near the nuclear membrane or in the nucleolus). Reaction products, however, were never seen at the plasma membrane level. These results provide immunocytological evidence for the presence of 1,25(OH)2D3 and its receptors in osteoblasts and osteocytes. The similar localization of the hormone and its receptors in osteoblasts and osteocytes supports the hypothesis of a direct action of 1,25(OH)2D3 in these bone cells. The fact that the main localization of 1,25(OH)2D3 receptors was nuclear, implies, as postulated for other steroid receptors, that 1,25(OH)2D3 receptors occur primarily in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2850050

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  15 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival.

Authors:  Zhang Xiaoyu; Biswas Payal; Owraghi Melissa; Laura P Zanello
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-08       Impact factor: 4.292

Review 3.  The biology of osteocytes.

Authors:  Giolanta Kogianni; Brendon S Noble
Journal:  Curr Osteoporos Rep       Date:  2007-06       Impact factor: 5.096

4.  Immunoreactive calbindin-D9K in bone matrix vesicle.

Authors:  N Balmain; D Hotton; P Cuisinier-Gleizes; H Mathieu
Journal:  Histochemistry       Date:  1991

5.  Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.

Authors:  R G Erben; H Weiser; F Sinowatz; W A Rambeck; H Zucker
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

6.  Localization of endogenous osteocalcin in neonatal rat bone and its absence in articular cartilage: effect of warfarin treatment.

Authors:  G Boivin; G Morel; J B Lian; C Anthoine-Terrier; P M Dubois; P J Meunier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  Calbindin-D9K immunolocalization and vitamin D-dependence in the bone of growing and adult rats.

Authors:  N Balmain; A Berdal; D Hotton; P Cuisinier-Gleizes; H Mathieu
Journal:  Histochemistry       Date:  1989

Review 8.  Is there a role for vitamin D in osteoporosis?

Authors:  C Lamberg-Allardt
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

9.  Evidence for a direct effect of growth hormone on osteoblasts.

Authors:  G Morel; P Chavassieux; B Barenton; P M Dubois; P J Meunier; G Boivin
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

10.  Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts.

Authors:  Xiaoyu Zhang; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.